DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Freedman MS, Forrestal FG.
Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon beta-1a: analysis of the PRISMS study.
Mult Scler 2008;
14 (09) 1234-1241
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.